Translational research in lung disease is paying off. In just the past decade, for example, research has led to a new therapy for lymphangioleiomyomatosis, which may also halt progression of this rare lung disease virtually unknown 15 years ago.
Media Coverage
|
American Journal of Respiratory and Critical Care